Panel Discussion: Evaluating Antigen-Specific vs Antigen-Non-Specific Approaches: Assessing ‘Tolerance’ to Benchmark Tolerizing Strategies

Time: 11:00 am
day: Conference Day One


  • Reviewing what we mean by ‘tolerance’ in autoimmune diseases to understand the end goal and refine biomarker, preclinical model, dosage, and delivery considerations
  • Discussing antigen-non-specific or antigen-agnostic approaches
  • Debating the possibilities of antigen-specific approaches for autoimmune diseases by looking cross-field to both allergy and transplant successes